CFTR Modulators: Impact on Fertility, Pregnancy, and Lactation in Women with Cystic Fibrosis

by Taylor-Cousar, Jennifer L.
Published in J Clin Med (2020)

The combination of tezacaftor and ivacaftor in the treatment of patients with cystic fibrosis: clinical evidence and future prospects in cystic fibrosis therapy

by Lommatzsch, Sherstin T., Taylor-Cousar, Jennifer L.
Published in Ther Adv Respir Dis (2019)

Fertility, Pregnancy and Lactation Considerations for Women with CF in the CFTR Modulator Era

by Jain, Raksha, Taylor-Cousar, Jennifer L.
Published in J Pers Med (2021)

Let’s Talk about Sex: Behaviors, Experience and Health Care Utilization in Young Women with CF

by Heltshe, Sonya L., Taylor-Cousar, Jennifer L.
Published in J Cyst Fibros (2017)

Challenges in the use of highly effective modulator treatment for cystic fibrosis

by Ramos, Kathleen J., Pilewski, Joseph M., Taylor-Cousar, Jennifer L.
Published in J Cyst Fibros (2021)

Restarting Respiratory Clinical Research in the Era of the Coronavirus Disease 2019 Pandemic

by Taylor-Cousar, Jennifer L., Maier, Lisa, Downey, Gregory P., Wechsler, Michael E.
Published in Chest (2021)

Elevated furin levels in human cystic fibrosis cells result in hypersusceptibility to exotoxin A–induced cytotoxicity

by Ornatowski, Wojciech, Poschet, Jens F., Perkett, Elizabeth, Taylor-Cousar, Jennifer L., Deretic, Vojo
Published 2007

Potential of anti-inflammatory treatment for cystic fibrosis lung disease

by Taylor-Cousar, Jennifer L, Von Kessel, Kelsey A, Young, Robert, Nichols, David P
Published 2010

PREGNANCY AMONG CYSTIC FIBROSIS WOMEN IN THE ERA OF CFTR MODULATORS

by Heltshe, Sonya L., Godfrey, Emily M., Josephy, Tatiana, Aitken, Moira L., Taylor-Cousar, Jennifer L.
Published in J Cyst Fibros (2017)

Corticosteroid use and increased CXCR2 levels on leukocytes are associated with lumacaftor/ivacaftor discontinuation in cystic fibrosis patients homozygous for the F508del CFTR mut...

by Pohl, Kerstin, Nichols, David P., Taylor-Cousar, Jennifer L., Saavedra, Milene T., Strand, Matthew J., Nick, Jerry A., Bratcher, Preston E.
Published in PLoS One (2018)

Contraceptive use among women with cystic fibrosis: A pilot study linking reproductive health questions to the Cystic Fibrosis Foundation National Patient Registry

by Godfrey, Emily M., Mody, Sheila, Schwartz, Malaika R., Heltshe, Sonya L., Taylor-Cousar, Jennifer L., Jain, Raksha, Sufian, Sandra, Josephy, Tatiana, Aitken, Moira L.
Published in Contraception (2020)

Oral Azithromycin Use and the Recovery of Lung Function from Pulmonary Exacerbations Treated with Intravenous Tobramycin or Colistimethate in Adults with Cystic Fibrosis

by Somayaji, Ranjani, Russell, Renee, Cogen, Jonathan D., Goss, Cristopher H., Nick, Sarah E., Saavedra, Milene T., Taylor-Cousar, Jennifer L., Nick, Jerry A., Nichols, Dave P.
Published in Ann Am Thorac Soc (2019)

Azithromycin May Antagonize Inhaled Tobramycin When Targeting Pseudomonas aeruginosa in Cystic Fibrosis

by Nick, Jerry A., Moskowitz, Samuel M., Chmiel, James F., Forssén, Anna V., Kim, Sun Ho, Saavedra, Milene T., Saiman, Lisa, Taylor-Cousar, Jennifer L., Nichols, David P.
Published 2014

Enhanced In Vitro Formation and Antibiotic Resistance of Nonattached Pseudomonas aeruginosa Aggregates through Incorporation of Neutrophil Products

by Caceres, Silvia M., Malcolm, Kenneth C., Taylor-Cousar, Jennifer L., Nichols, David P., Saavedra, Milene T., Bratton, Donna L., Moskowitz, Samuel M., Burns, Jane L., Nick, Jerry A.
Published in Antimicrob Agents Chemother (2014)

Histo-Blood Group Gene Polymorphisms as Potential Genetic Modifiers of Infection and Cystic Fibrosis Lung Disease Severity

by Taylor-Cousar, Jennifer L., Zariwala, Maimoona A., Burch, Lauranell H., Pace, Rhonda G., Drumm, Mitchell L., Calloway, Hollin, Fan, Haiying, Weston, Brent W., Wright, Fred A., Knowles, Michael R.
Published 2009

Impact of azithromycin on the clinical and antimicrobial effectiveness of tobramycin in the treatment of cystic fibrosis

by Nichols, Dave P., Happoldt, Carrie L., Bratcher, Preston E., Caceres, Silvia M., Chmiel, James F., Malcolm, Kenneth C., Saavedra, Milene T., Saiman, Lisa, Taylor-Cousar, Jennifer L., Nick, Jerry A.
Published in J Cyst Fibros (2016)

Clinical development of triple-combination CFTR modulators for cystic fibrosis patients with one or two F508del alleles

by Taylor-Cousar, Jennifer L., Mall, Marcus A., Ramsey, Bonnie W., McKone, Edward F., Tullis, Elizabeth, Marigowda, Gautham, McKee, Charlotte M., Waltz, David, Moskowitz, Samuel M., Savage, Jessica, Xuan, Fengjuan, Rowe, Steven M.
Published in ERJ Open Res (2019)

Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor for 24 Weeks or Longer in People with Cystic Fibrosis and One or More F508del Alleles: Interim Results of an Open-Label Phas...

by Griese, Matthias, Costa, Stefano, Linnemann, Rachel W., Mall, Marcus A., McKone, Edward F., Polineni, Deepika, Quon, Bradley S., Ringshausen, Felix C., Taylor-Cousar, Jennifer L., Withers, Nicholas J., Moskowitz, Samuel M., Daines, Cori L.
Published in Am J Respir Crit Care Med (2021)

Neutrophil Extracellular Trap (NET)-Mediated Killing of Pseudomonas aeruginosa: Evidence of Acquired Resistance within the CF Airway, Independent of CFTR

by Young, Robert L., Malcolm, Kenneth C., Kret, Jennifer E., Caceres, Silvia M., Poch, Katie R., Nichols, David P., Taylor-Cousar, Jennifer L., Saavedra, Milene T., Randell, Scott H., Vasil, Michael L., Burns, Jane L., Moskowitz, Samuel M., Nick, Jerry A.
Published 2011

Mycobacterium abscessus Induces a Limited Pattern of Neutrophil Activation That Promotes Pathogen Survival

by Malcolm, Kenneth C., Nichols, E. Michelle, Caceres, Silvia M., Kret, Jennifer E., Martiniano, Stacey L., Sagel, Scott D., Chan, Edward D., Caverly, Lindsay, Solomon, George M., Reynolds, Paul, Bratton, Donna L., Taylor-Cousar, Jennifer L., Nichols, David P., Saavedra, Milene T., Nick, Jerry A.
Published 2013